氨基己糖苷酶Bβ(HEXb)重组蛋白
Recombinant Hexosaminidase B Beta (HEXb)
Hex-B; ENC-1AS; HCC-7; Beta-N-acetylhexosaminidase subunit beta; Cervical cancer proto-oncogene 7 protein; N-acetyl-beta-glucosaminidase subunit beta
- 编号RPA637Mu01
- 物种Mus musculus (Mouse，小鼠)相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位溶酶体
- 预测分子量14.7kDa
- 实际分子量14kDa(差异分析请参阅说明书)
- 片段与标签Pro101~Ile217 (Accession # P20060) with N-terminal His Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 97%
- 等电点6.17
- 应用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载英文说明书 中文说明书
- 规格10µg50µg200µg1mg5mg
- 价格¥ 1152¥ 2880¥ 5760¥ 17280¥ 43200
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
SDS-PAGE图
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA637Mu01 | 氨基己糖苷酶Bβ(HEXb)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA637Mu02 | 氨基己糖苷酶Bβ(HEXb)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA637Mu01 | 氨基己糖苷酶Bβ(HEXb)多克隆抗体 | WB; IHC; ICC; IP. |
| PAA637Mu02 | 氨基己糖苷酶Bβ(HEXb)多克隆抗体 | WB; IHC; ICC; IP. |
| SEA637Mu | 氨基己糖苷酶Bβ(HEXb)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA637Mu | 氨基己糖苷酶Bβ(HEXb)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| The American Journal of Chinese Medicine | Uncovering the Molecular Mechanism of Anti-Allergic Activity of Silkworm Pupa-Grown Cordyceps militaris Fruit Body.[pubmed:28367714] |
| Life Sciences | Resveratrol efficiently improves pulmonary function via stabilizing mast cells in a rat intestinal injury model[pubmed:28733146] |
| Neural Regen Res | Functionality of a bicistronic construction containing HEXA and HEXB genes encoding ¦Â-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses[34100447] |
| Nat Commun | The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets[34099640] |